Michal Tsur

Found 1 recent publications

Aug 12, 2026

Startups

Michal Tsur's startup Remepy raises $36 million for the development of hybrid drugs

Remepy has raised $36 million in a Series A funding round. The startup develops hybrid drugs that combine prescription medication with AI-based therapeutic applications.

Showing latest 50 articles for this tag